Vascarta Inc., a healthspan focused, clinical stage biopharmaceutical company advancing safe, patient friendly ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

Real life is indeed stranger than fiction. In a dusty settlement on the outskirts of Kano, aid workers arrived one morning to distribute nutritional supplements to malnourished children. Among the ...

Pain is a constant, complex companion that clinicians often struggle to understand and measure for people living with sickle ...

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...

One of the most vital treatments for sickle cell patients is regular blood transfusions; sometimes, it's needed multiple times a year.

Pain is a constant, complex companion that clinicians often struggle to understand and measure for people living with sickle ...

A new study led by Carnegie Mellon’s Wood Neuro Research Group is using brain imaging and digital visualization to uncover ...

One of the most vital treatments for sickle cell patients is regular blood transfusions; sometimes, it's needed multiple ...

Columnist Oluwatosin Adesoye encourages medical professional to be more mindful about the care they provide to sickle cell ...